F&C hopes fee cut and performance beat will light up shares
F&C Investment Trust’s shares struggle to make headway despite manager Paul Niven growing the portfolio and the board negotiating a fee cut.
Investment company news brought to you by Citywire Financial Publishers Limited and Quoted Data by Marten & Co.
Keystone: Former Saba target’s wind-down plan achieves 99% approval
Investors in Baillie Gifford’s Keystone Positive Change have voted overwhelmingly in favour of liquidating the fund after a tumultuous few months fighting Saba Capital.
Schroders Capital Global’s bumper first sale after wind-down vote
The former Woodford Patient Capital fund offloads its first holding after shareholders voted for a managed wind-down at the end of February.
Onward Opportunities delivers best in class returns for 2024
Onward Opportunities Limited (ONWD) announced its annual results for the 12 months to 31 December 2024. The company delivered a NAV total return of 21...
Harworth posts 9.1% return in 2024
Harworth Group delivered a NAV total return of 9.1% over 2024, after seeing EPRA net disposal value (NDV) increase 8.5% driven by gains on development...
QuotedData’s morning briefing 18 March 2025 – SHIP, SERE
In QuotedData’s morning briefing 18 March 2025: Tufton Assets (SHIP) announced its interim results for the six month period ended 31 December 2024. Th...
Putin permits sale of some Russian stocks, but not for JEMA
Putin has published a decree that says that certain firms owning Russian stocks will be able to sell these to a New York based hedge fund – 683 Partne...
Harmony Energy leads battery funds higher after £191m Foresight offer
Foresight Group has made an attractive offer for Harmony Energy Income, which has been in the process of selling down its assets after failing to gain traction.
Schroders Capital Global Innovation’s Araris Biotech sold to Taiho Pharmaceutical
Schroders Capital Global Innovation (INOV) has announced that its portfolio company Araris Biotech AG, has entered into an agreement to be acquired by...
Broker rubbishes Schroder British Opps’ plan to go 100% private
Schroder British Opportunities announces plan to ditch public holdings after they have held back performance, but Panmure Liberum analyst Joachim Klement finds the move ‘disingenuous’.
James Carthew: My China fund is up 60% in six months and has further to go
As US markets finally come off the boil, our columnist explains why he is sticking with Fidelity China Special Situations and how the £1.4bn trust makes good use of the closed-end structure.
Bellevue Healthcare’s board focused on improving performance
Bellevue Healthcare (BBH) has published its annual results for the year ended 30 November 2024, during which it provided NAV and share price total ret...
